USP Signs Agreements with Chinese Drug Control Authorities

As part of its efforts to improve the quality of medicines and food ingredients worldwide, the US Pharmacopeial (USP) Convention has reached three new cooperative agreements with Chinese drug control authorities.

These agreements, coupled with three previous agreements between USP and other government organizations in China, mark a commitment to ensure that concerns about quality are addressed.

At a June 18 ceremony in Guangzhou, China, Roger Williams, USP's CEO, signed a Memorandum of Understanding (MOU) with the Guangzhou Municipal Institute of Drug Control.

USP has also signed MOUs with the Beijing Municipal Institute of Drug Control and the Zhejiang Institute for Food and Drug Control. All are focused on strengthening the relationships through such initiatives as scientist exchange programs, joint standards- and testing-related work, and other projects to improve drug quality that will benefit from the expertise of both parties.